Spending on prescription drugs in the USA was up by 12% in 2014, faster than in any year since 2002, according to the Centers for Medicare & Medicaid Services (CMS), which is one of the largest purchasers of prescription drugs in the USA.
Hefty price increases for a number of prescription drugs contributed to higher spending by the US Medicare program in 2014, according to new government data released Monday.
The CMS said, total Medicare spending on prescription drugs accelerated during 2014, rising 16.9% against 9.5% in 2013.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze